What is the appropriate oral cephalexin (Keflex) dose for an 11-year-old with an open finger fracture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cephalexin Dosing for Open Finger Fracture in 11-Year-Old

For an 11-year-old with an open finger fracture, administer cephalexin 25-50 mg/kg/day divided into 3-4 doses (maximum 500 mg per dose), for 3 days, starting as soon as possible after injury.

Rationale and Dosing Details

Open fractures require prompt antibiotic prophylaxis to prevent infection. For Gustilo-Anderson Grade I and II open fractures (which most finger fractures are), first-generation cephalosporins like cephalexin provide appropriate coverage against Staphylococcus aureus, streptococci, and common gram-negative organisms 1.

Specific Dosing Recommendations

The FDA-approved pediatric dosing for cephalexin is 25-50 mg/kg/day in divided doses 2. For skin and soft tissue infections (which open fractures fall under), the total daily dose may be divided and administered every 12 hours 2. However, for more serious infections requiring optimal coverage:

  • Standard dosing: 25-50 mg/kg/day divided every 6-8 hours (QID or TID)
  • Maximum single dose: 500 mg per dose for children
  • Duration: 3 days for Grade I/II open fractures 1

For a typical 11-year-old weighing approximately 35-40 kg, this translates to roughly 350-500 mg every 6-8 hours.

Important Clinical Considerations

Start antibiotics immediately - delay beyond 3 hours increases infection risk 1. The antibiotic should be administered as soon as possible after injury, ideally before surgical debridement.

Grade-specific coverage: If this is a simple Grade I or II open finger fracture, cephalexin (or cefazolin IV initially, then oral cephalexin) provides adequate coverage 3, 4, 1. The 2014 IDSA guidelines support cephalexin 25-50 mg/kg/day in 3-4 divided doses for MSSA skin and soft tissue infections 4.

Duration matters: Continue for 3 days for Grade I/II fractures. If the fracture is Grade III or has significant contamination, extend to 5 days and consider adding gram-negative coverage 1.

Alternative Considerations

If the child cannot tolerate oral medications initially or the fracture requires immediate surgical intervention, start with IV cefazolin 50 mg/kg/day in 3 divided doses (maximum 12 g/day), then transition to oral cephalexin once the child can take oral medications 4.

For penicillin-allergic patients (non-immediate hypersensitivity): Cephalexin remains appropriate. For immediate-type hypersensitivity, use clindamycin 20 mg/kg/day in 3 divided doses 4.

Common Pitfalls

  • Don't underdose: Using adult dosing (250 mg QID) in children results in subtherapeutic levels
  • Don't delay: Antibiotics must start within 3 hours of injury for optimal infection prevention
  • Don't extend unnecessarily: Grade I/II fractures only need 3 days, not the full 10 days used for streptococcal pharyngitis
  • Don't forget tetanus: Ensure tetanus prophylaxis is current

The evidence strongly supports first-generation cephalosporins as the antibiotic of choice for simple open fractures in children, with cephalexin being the preferred oral agent due to its narrow spectrum, safety profile, and proven efficacy 3, 4, 1, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.